908 Devices (MASS) announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Otitoju brings over 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he served as Senior Vice President of Strategy & Business Development at Repligen Corporation.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASS:
- 908 Devices’ Smaller-Reporting Status May Curb Transparency, Weigh on Investor Appeal and Volatility
- 908 Devices files $100M mixed securities shelf
- 908 Devices Earnings Call Signals Gradual Turnaround
- 908 Devices reports Q4 EPS 10c, consensus (5c)
- 908 Devices sees FY26 revenue $64.5M-$67.5M, consensus $65.38M